4Front Presents Brighleaf Brands To Massachusetts Market

4Front Ventures Corp. FFNT FFNTF said Monday that upon completing its merger with Cannex, it has worked on making Cannex’s operating capabilities part of 4Front’s manufacturing division Brightleaf set for the Massachusetts market.

"To say I am proud of my team is an understatement," Leo Gontmakher, 4Front COO, said in a statement. "Taking advantage of our pre-merger planning work, we formally took over 4Front's production and processing operations in August. By late September, we had introduced Marmas and Pebbles, two of our most successful edibles brands, to the Massachusetts' medical cannabis market. Most importantly to me, we successfully replicated the low-cost production methods we developed in Washington."

Click here for more information about the upcoming Benzinga Cannabis Capital Conference Oct. 22-23 in Chicago.

Josh Rosen, 4Front CEO, also commented on the news.

“We are executing against a simple strategy: bringing highly efficient and battle-tested operating capabilities to nascent markets. In this case, Leo and team were able to quickly implement these capabilities in a new market to achieve stellar initial results," he said.

Rosen added that the company is getting close to acquiring adult-use licenses in its Massachusetts facilities.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: CannabisNewsMarketsCannexLeo Gontmakher
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!
CCC-Oct-24-Banner-1

Click on the image for more info.

Cannabis rescheduling seems to be right around the corner

Want to understand what this means for the future of the industry?

Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. 

Get your tickets now before prices surge by following this link.